The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer
…, M Gent, J Hirsh, A Arnold, MD Goodyear… - … England Journal of …, 1988 - Mass Medical Soc
Thromboembolic disease has long been recognized as a complication of cancer. Recent
reports have suggested that drugs used in the treatment of cancer, including chemotherapeutic …
reports have suggested that drugs used in the treatment of cancer, including chemotherapeutic …
RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute …
…, K Winter, RJ Myerson, MD Goodyear… - International Journal of …, 2013 - Elsevier
PURPOSE: A multi-institutional phase 2 trial assessed the utility of dose-painted intensity
modulated radiation therapy (DP-IMRT) in reducing grade 2+ combined acute gastrointestinal …
modulated radiation therapy (DP-IMRT) in reducing grade 2+ combined acute gastrointestinal …
Quality of life in stage II breast cancer: an instrument for clinical trials.
…, M Gent, S De Pauw, MD Goodyear… - Journal of Clinical …, 1988 - ascopubs.org
A questionnaire has been developed for use as an outcome measure in clinical trials of
adjuvant chemotherapy in women with stage II breast cancer. The selection of items for this …
adjuvant chemotherapy in women with stage II breast cancer. The selection of items for this …
Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the …
…, GJ O'Connell, CR Johanson, MD Goodyear… - Gynecologic …, 1995 - Elsevier
In 1982, a treatment protocol was instituted for the management of patients with clinical stage
I adenocarcinoma of the endometrium. All pertinent historical, operative, and pathologic …
I adenocarcinoma of the endometrium. All pertinent historical, operative, and pathologic …
Long-term outcomes of NRG oncology/RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and …
…, KA Winter, RJ Myerson, MD Goodyear… - International Journal of …, 2022 - Elsevier
Purpose A multi-institutional phase 2 trial assessed long-term outcomes of dose-painted
intensity modulated radiation therapy (IMRT) with 5-fluorouracil (5FU) and mitomycin-C (MMC) …
intensity modulated radiation therapy (IMRT) with 5-fluorouracil (5FU) and mitomycin-C (MMC) …
Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted …
M Refaei, B Fernandes, J Brandwein, MD Goodyear… - Annals of …, 2016 - Springer
… Marilyn Dawn Goodyear … Marilyn Dawn Goodyear … MD Goodyear has received
research grants from Bayer and Pfizer. The rest of the authors declare no conflict of interest. …
research grants from Bayer and Pfizer. The rest of the authors declare no conflict of interest. …
Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
GP Browman, MD Goodyear, MN Levine… - Journal of Clinical …, 1990 - ascopubs.org
Randomized trials comparing high-dose methotrexate (HDMTX) plus leucovorin (LV) with
standard-dose methotrexate (SDMTX) have not detected a therapeutic advantage for the …
standard-dose methotrexate (SDMTX) have not detected a therapeutic advantage for the …
The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.
RM Meyer, WM Hryniuk, MD Goodyear - Journal of clinical oncology, 1991 - ascopubs.org
To determine whether the dose intensity of chemotherapeutic regimens correlates with the
complete remission rate in adult patients with advanced-stage intermediate-grade lymphoma, …
complete remission rate in adult patients with advanced-stage intermediate-grade lymphoma, …
Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: a 10-year provincial retrospective cohort study
D Sawler, A Parker, J Britto, MD Goodyear, HL Sun - Thrombosis research, 2020 - Elsevier
… MD Goodyear designed the study, contributed to data interpretation and critical review of the
manuscript. HL Sun designed the study, contributed to data analysis and interpretation, and …
manuscript. HL Sun designed the study, contributed to data analysis and interpretation, and …
Diastereoselective synthesis of the potent antiviral agent (-)-2'-deoxy-3'-thiacytidine and its enantiomer
…, HLA Tse, TS Mansour, MD Goodyear… - The Journal of …, 1995 - ACS Publications
The discovery of the potent anti-human immunodefi-ciency virus (HIV) properties of 3'-azido-3'-deoxythymidine
(AZT) has stimulated intensive efforts in the field of nucleosides …
(AZT) has stimulated intensive efforts in the field of nucleosides …
